| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer
|
Dolly, Saoirse O.
|
|
2017
|
77 |
8 |
p. 813-827
|
artikel
|
| 2 |
Avelumab: First Global Approval
|
Kim, Esther S.
|
|
|
77 |
8 |
p. 929-937
|
artikel
|
| 3 |
Avelumab: First Global Approval
|
Kim, Esther S.
|
|
2017
|
77 |
8 |
p. 929-937
|
artikel
|
| 4 |
Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions
|
Lund, Marie
|
|
2017
|
77 |
8 |
p. 859-883
|
artikel
|
| 5 |
Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4
|
Al-Salama, Zaina T.
|
|
2017
|
77 |
8 |
p. 911-921
|
artikel
|
| 6 |
Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
|
Banerjee, Shubhasree
|
|
2017
|
77 |
8 |
p. 939
|
artikel
|
| 7 |
Medical Expulsive Therapy: Is It Time to SUSPEND Judgement?
|
Amer, Tarik
|
|
2017
|
77 |
8 |
p. 809-812
|
artikel
|
| 8 |
Naldemedine: First Global Approval
|
Markham, Anthony
|
|
2017
|
77 |
8 |
p. 923-927
|
artikel
|
| 9 |
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
|
Nandoskar, A.
|
|
2017
|
77 |
8 |
p. 885-910
|
artikel
|
| 10 |
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
|
Santos, Alicia
|
|
2017
|
77 |
8 |
p. 829-842
|
artikel
|
| 11 |
Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
|
Moreira, Jonathan
|
|
|
77 |
8 |
p. 843-857
|
artikel
|
| 12 |
Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
|
Moreira, Jonathan
|
|
2017
|
77 |
8 |
p. 843-857
|
artikel
|
Tijdschrift beschrijving